Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-02-2018 | Original Article – Cancer Research

Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer

Authors: Jizhen Li, Yi Liao, Jintuan Huang, Yi Sun, Hao Chen, Chunyu Chen, Senmao Li, Zuli Yang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 2/2018

Abstract

Purpose

A disintegrin and metalloprotease with motif 5(ADAMTS5) has been involved in colorectal cancer (CRC) with hypermethylation in the promoter. However, its role in CRC remains unclear. The aim of this study was to explore the clinical significance and biological effect of ADAMTS5 on colorectal carcinogenesis. Through MSP, qRT-PCR, WB and IHC analysis, followed by a variety of in vitro assays, we report the function of ADAMTS5 in CRC. ADAMTS5 was markedly hypermethylaed and downregulated in tumor tissues compared with non-tumor tissues (p < 0.001). Negative expression of ADAMTS5 was much more common in tumor tissues than that in normal tissues (p < 0.001) and correlated with histologic types (p = 0.002), poor OS (p = 0.029) and DFS (p = 0.018). In vitro assay revealed that overexpression of ADAMTS5 inhibited the capabilities of migration and invasion of CRC cells, and no effect on cell growth, cell cycle and apoptosis. ADAMTS5 is hypermethylated and inhibits cancer cells invasion and migration in colorectal cancer, and correlates with OS and DFS, indicating that ADAMTS5 might be a useful biomarker in colorectal cancer therapy.

Available only for authorised users

Apte SS (2009) A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 284:31493–31497. https://doi.org/10.1074/jbc.R109.052340 CrossRefPubMedPubMedCentral

Choi GCG et al (2014) The Metalloprotease ADAMTS8 Displays Antitumor Properties through Antagonizing EGFR-MEK-ERK Signaling and Is Silenced in Carcinomas by CpG Methylation. Mol Cancer Res 12:228–238. https://doi.org/10.1158/1541-7786.MCR-13-0195 CrossRefPubMed

Cross NA, Chandrasekharan S, Jokonya N, Fowles A, Hamdy FC, Buttle DJ, Eaton CL (2005) The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate 63:269–275. https://doi.org/10.1002/pros.20182 CrossRefPubMed

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917. https://doi.org/10.1002/ijc.25516 CrossRefPubMed

Gu J et al (2016) Overexpression of ADAMTS5 can regulate the migration and invasion of non-small cell lung. Cancer Tumor Biol 37:8681–8689. https://doi.org/10.1007/s13277-015-4573-x CrossRef

Held-Feindt J, Paredes EB, Blomer U, Seidenbecher C, Stark AM, Mehdorn HM, Mentlein R (2006) Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. Int J Cancer 118:55–61. https://doi.org/10.1002/ijc.21258 CrossRefPubMed

Kim YH et al (2011) Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. Ann Surg Oncol 18:2338–2347. https://doi.org/10.1245/s10434-011-1573-y

Kintakas C, McCulloch DR (2011) Emerging roles for ADAMTS5 during development and disease. Matrix Biol J Int Soc Matrix Biol 30:311–317. https://doi.org/10.1016/j.matbio.2011.05.004 CrossRef

Koo BH, Hurskainen T, Mielke K, Aung PP, Casey G, Autio-Harmainen H, Apte SS (2007) ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer International. J Cancer 121:1710–1716. https://doi.org/10.1002/ijc.22882

Kumar S, Sharghi-Namini S, Rao N, Ge RW (2012) ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity American. J Pathol 181:1056–1068. https://doi.org/10.1016/j.ajpath.2012.05.022

Li Z et al (2010) High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers. Med Oncol 27:998–1004. https://doi.org/10.1007/s12032-009-9323-8 CrossRefPubMed

Li C et al (2015) Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma. Drug Des Dev Therapy 9:1773–1783. https://doi.org/10.2147/DDDT.S77069 CrossRef

Lima MA et al (2016) Prognostic Value of ADAMTS Proteases and Their Substrates in Epithelial. Ovarian Cancer Pathobiol 83:316–326. https://doi.org/10.1159/000446244

Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA (2006) ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol 28:259–272PubMedPubMedCentral

Moncada-Pazos A et al (2009) The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J Cell Sci 122:2906–2913. https://doi.org/10.1242/jcs.050468 CrossRefPubMed

Porter S et al (2004) Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res 10:2429–2440CrossRef

Stanton H et al (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648–652. https://doi.org/10.1038/nature03417 CrossRefPubMed

Tiscornia G, Singer O, Verma IM (2006) Production and purification of lentiviral vectors. Nat Protocols 1:241–245. https://doi.org/10.1038/nprot.2006.37 CrossRefPubMed

Viloria CG et al (2009) Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res 69:4926–4934. https://doi.org/10.1158/0008-5472.CAN-08-4155 CrossRefPubMed

Yang ZL et al. (2014) Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer BMC cancer 14 Artn. 568. https://doi.org/10.1186/1471-2407-14-568

Yang Z et al (2015) Epigenetic inactivation and tumor-suppressor behavior of NGFR in human colorectal cancer. MCR 13:107–119. https://doi.org/10.1158/1541-7786.MCR-13-0247 CrossRefPubMed

Zhang C et al (2010) High-resolution melting analysis of ADAMTS9 methylation levels in gastric, colorectal, and pancreatic cancers. Cancer Genet Cytogenet 196:38–44. https://doi.org/10.1016/j.cancergencyto.2009.08.016 CrossRefPubMed

Title: Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer
Authors: Jizhen Li
Yi Liao
Jintuan Huang
Yi Sun
Hao Chen
Chunyu Chen
Senmao Li
Zuli Yang
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: Journal of Cancer Research and Clinical Oncology / Issue 2/2018
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-017-2545-9

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer

Abstract

Purpose

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Please log in to get access to this content

Other articles of this Issue 2/2018

Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation

The risk of lung cancer among cooking adults: a meta-analysis of 23 observational studies

Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis

Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets

Model-based optimization of G-CSF treatment during cytotoxic chemotherapy

Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page